Oramed Pharmaceuticals
ORMP
#8739
Rank
โ‚น18.17 B
Marketcap
โ‚น449.47
Share price
3.60%
Change (1 day)
134.72%
Change (1 year)

Market capitalization of Oramed Pharmaceuticals (ORMP)

Market cap: โ‚น18.17 Billion

As of May 2026 Oramed Pharmaceuticals has a market cap of โ‚น18.17 Billion. This makes Oramed Pharmaceuticals the world's 8739th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Oramed Pharmaceuticals from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น18.17 B72.27%
2025โ‚น10.55 B28.75%
2024โ‚น8.19 B5.65%
2023โ‚น7.75 B-80.08%
2022โ‚น38.93 B-3.99%
2021โ‚น40.55 B449.32%
2020โ‚น7.38 B15.54%
2019โ‚น6.39 B75.3%
2018โ‚น3.64 B-55.66%
2017โ‚น8.22 B49%
2016โ‚น5.51 B-16.3%
2015โ‚น6.59 B110.97%
2014โ‚น3.12 B-58.76%
2013โ‚น7.57 B384.73%
2012โ‚น1.56 B50.52%
2011โ‚น1.03 B31.46%
2010โ‚น0.78 B-33.66%
2009โ‚น1.19 B12.51%
2008โ‚น1.05 B

End of Day market cap according to different sources

On May 13th, 2026 the market cap of Oramed Pharmaceuticals was reported to be:

โ‚น17.55 Billion
by Nasdaq info icon info icon
โ‚น17.55 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novo Nordisk
NVO
โ‚น19.454 T 106,913.89%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น9.748 T 53,526.06%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
โ‚น244.37 B 1,244.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น100.05 B 450.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น26.85 B 47.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel